The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

The Cancer Drug Development Forum (CDDF) has published its executive summary of the workshop on “Dose Optimization in Early Oncology Drug Development.”

The multi-stakeholder workshop took place on 3-4 April 2023 in Amsterdam, NL. The gathering brought together the community of cancer drug development in order to discuss how dose optimization could be implemented in early drug development in the future based on new methodologies, considering various views of all stakeholders.

Together with renowned speakers and audiences with diverse backgrounds, it generated fruitful discussions and interactive dialogue, placing strong emphasis on collaborative approaches to move forward in this area.

📜 To learn more about our discussions, here is the executive summary

📺 To get a glimpse of the workshop, here is the video

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70